Crossref
Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma
Journal of the Advanced Practitioner in Oncology · 01.06.2017 · 8 (4)
DOI: 10.6004/jadpro.2017.8.4.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 01.06.2017. Verfasst von Krista G. Ramirez und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ramirez, K. G., PharmD, & BCPS (2017). Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma. Journal of the Advanced Practitioner in Oncology, 8(4). https://doi.org/10.6004/jadpro.2017.8.4.9
Vancouver
Ramirez KG, PharmD, BCPS. Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma. Journal of the Advanced Practitioner in Oncology. 2017;8(4). doi:10.6004/jadpro.2017.8.4.9
BibTeX
@article{Ramirez2017,
author = {Ramirez, Krista G. and PharmD and BCPS},
title = {Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma},
journal = {Journal of the Advanced Practitioner in Oncology},
year = {2017},
volume = {8},
number = {4},
doi = {10.6004/jadpro.2017.8.4.9}
}
EUVIMED